Making Reinvention Real with Gen AI

This report by Criticaleye Partner Accenture reflects on the lessons learned from the past year of Gen AI project delivery, offering actionable insights for leaders looking to implement and scale this transformative technology. This research reinforces the value of acting across all five imperatives that were identified in Accenture's 2024 Reinvention in the Age of Generative AI report.
 
Key takeaways include:

  • Organisations scaling Gen AI successfully are four-and-a-half times more likely to invest in agentic architecture - building the foundation for continuous reinvention
  • Three times more Gen AI budgets are spent on technology than on people
  • CEO sponsored Gen AI-enabled enterprise reinvention typically delivers two-and-a-half times more value




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Destination Net Zero: Fast-Tr...

The race to net zero is well underway, but how fast are companies really progressing? Criticaleye Partner Accenture’s Destination Net Zero report sheds light on this question. Drawing on data from the world&r...

Click here to download this insight
Ready for Resilience: Navigat...

In this report by Criticaleye Partner Accenture, the evolving global trade landscape is examined in the wake of sweeping U.S. tariffs. Macroeconomic impacts are analysed, and four essential capabilities for buildin...

Inspiring Leaders Podcast: Al...

Alison Gowen, Group HRD at AG Barr plc and Neil Hayward, Chair at Skills Union, discuss how CPOs and senior HR leaders can effectively align strategic HR objectives with broader business goals. Hosted by Bridgette H...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 493




London Stock Exchange Group Accenture Workday E.ON UK Palo Alto Networks IBM Consulting Eightfold AI FTSE Women Leaders Review Royal London Group Amazon UK Drax Group plc LDC AlixPartners Lightsource bp Rolls-Royce Concentrix Legal & General Investment Management GlaxoSmithKline plc NATS Experian Salesforce Google Hitachi Solutions